财务表现 - 公司2023财年净收入为4.719亿美元，同比增长30.3%，净收入为2560万美元，同比增长2033.3%，调整后EBITDA为4830万美元，同比增长198.1%[312] - 2023财年净收入为4.71857亿美元，同比增长30%，主要受价格相关增长5940万美元和销量相关增长5050万美元的推动[340] - 2023财年毛利率为34%，较2022财年的30%有所提升，主要得益于销量增长和2023年1月的价格上调[342] - 2023财年销售、一般及行政费用为1.01728亿美元，同比增长32%，主要由于品牌和产品营销投入增加1020万美元，以及员工相关成本增加1020万美元[343] - 2023财年运输和分销费用为2734.4万美元，同比下降9%，主要由于运费率下降和内部运营效率提升[344] - 2023财年利息收入为254.2万美元，同比增长156%，主要由于可供出售证券组合的利息收入增加[346] - 2023财年其他费用净额为281.3万美元，同比增长1763%，主要由于商品衍生工具亏损[347] - 2023财年所得税费用为663.5万美元，同比增长314%，主要由于税前净收入增加[348] - 2023财年包含53周，额外一周贡献了850万美元的净收入，占增长的2.3%[341] - 2023财年运营收入为3325.4万美元，占净收入的7%，较2022财年的1%显著提升[338] - 2023财年净收入中，零售渠道销售额为4.458亿美元，较2022财年的3.489亿美元有所增长[340] - 2023年调整后EBITDA为4834.8万美元，同比增长197.8%[355] - 2023年净利润为2556.6万美元，同比增长1978.5%[355] - 2023年经营活动现金流为5090.6万美元，同比大幅改善[366] - 2023年底公司持有现金及现金等价物7123.5万美元，同比大幅增长[366] - 截至2023年12月31日，公司持有现金及现金等价物8410万美元，可供出售证券投资3270万美元[389] 成本与支出 - 公司预计2024财年因新农场建设成本增加，将产生1000万至1200万美元的增量农场招募成本，这些成本将在4至5年的合同期内分摊[308] - 公司预计2024财年将面临通胀压力，包括材料成本、利率和劳动力成本的上升，可能对运营资本造成压力[314] - 公司预计2024年资本支出约为1000万美元，用于新建鸡蛋包装设施[360] - 公司预计2024年营销支出将增加，以支持长期营销目标[360] - 2023年公司库存增加部分抵消了经营现金流的改善[367] 市场份额与销售 - 公司在美国鸡蛋零售市场的渗透率为7.5%，而整个鸡蛋类别的家庭渗透率为96.5%，计划通过销售和营销投资进一步扩大市场份额[320] - 公司产品在Whole Foods的零售销售额占比约为23%，2023财年共有约24,000家商店销售其产品[321][323] - 公司计划通过食品服务渠道扩展市场份额，并与Acxion Foodservice合作，增加在餐饮服务领域的市场份额[324] - 公司产品需求呈现季节性波动，节假日期间需求最高[371] 供应链与运营 - 公司拥有超过300家家庭农场作为鸡蛋供应网络，并通过高度自动化的Egg Central Station设施每天处理约600万枚鸡蛋[307][310] - 公司预计2024财年将面临高致病性禽流感（HPAI）带来的供应链风险，尽管目前尚未对鸡蛋供应造成重大影响[313] - 公司计划通过创新和产品扩展，继续加强其产品组合，2023财年鸡蛋及相关产品贡献了4.49亿美元的收入，占总收入的95%[327] 资金与流动性 - 公司截至2023年12月31日拥有1.168亿美元的现金及等价物和2000万美元的信贷额度，预计未来12个月内将有足够的流动性支持长期增长战略[315] - 公司预计未来12个月现有资金和信贷额度足以支持运营[359] - 2023年公司未偿还任何信贷额度，且符合所有信贷协议条款[365] 风险与挑战 - 公司面临商品价格波动风险，特别是鸡蛋和奶油的价格波动，2023年12月31日，假设这些原材料成本增加或减少10%，将导致销售成本增加或减少约880万美元[386] - 包装材料成本波动风险，2023年12月31日，假设包装原材料成本增加或减少10%，将导致销售成本增加或减少约350万美元[387] - 公司面临利率风险，但2023年12月31日，假设利率变化10%，不会对公司的经营结果或财务状况产生重大影响[388] - 公司选择利用JOBS法案的延长过渡期，可能导致其财务报表与其他上市公司不可比[384] 投资与证券 - 公司投资证券的有效到期日约为4个月，综合信用评级为Aa3（穆迪评级）[389] - 公司未在2023财年使用任何衍生金融工具来管理利率风险[390]

Exhibit 99.1 Vital Farms Reports Fourth Quarter and Fiscal Year 2023 Financial Results Record Fourth Quarter Net Revenue of $135.8 million, up 23.4% versus Prior Year Period Provides Fiscal Year 2024 Outlook AUSTIN, TX – March 7, 2024 – Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today reported financial results for its fourth quarter (14 weeks) and fiscal year (53 weeks) ended December 31, 2023. Financial highlights for the fourth quarte ...

I Sonja Filitz In the spring of last year, I called Vital Farms (NASDAQ:VITL) a long term secular growth play, one which has seen quite some pressure on its shares. Such pressure observed in the share price, in combination with continued sales growth, has narrowed sales multiple amidst rather non-existing margins, although some progress was anticipated on this front in 2023. Given the continued growth and potential for margin expansion, I was gradually warming up to shares of Vital in their mid-teens. While ...

Vital Farms, Inc. (NASDAQ:VITL) Q3 2023 Results Conference Call November 2, 2023 8:30 AM ET Company Participants Matt Siler - VP, IR Russell Diez-Canseco - President and CEO Thilo Wrede - CFO Pete Pappas - Chief Sales Officer Conference Call Participants Pamela Kaufman - Morgan Stanley Adam Samuelson - Goldman Sachs Matt Smith - Stifel Robert Moskow - TD Cowen Robert Dickerson - Jefferies Matt McGinley - Needham Ryan Meyers - Lake Street Capital Markets Matt Siler Thank you. Good morning. Welcome to Vital F ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 24, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Commission File Number: 001-39411 Vital Farms, Inc. (Exact name of registrant as specified in its charter) Delaware 27-04 ...

Vital Farms, Inc. (NASDAQ:VITL) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Matthew Siler - VP, IR Russell Diez-Canseco - President and CEO Thilo Wrede - CFO Peter Pappas - Chief Sales Officer Conference Call Participants Pamela Kaufman - Morgan Stanley Cody Ross - UBS Matt McGinley - Needham Matt Smith – Stifel Robert Dickerson - Jefferies Ben Klieve - Lake Street Capital Markets Robert Moskow - TD Cowen Operator Good day, and thank you for standing by. Welcome to the Vi ...

VITAL FARMS, INC. (NASDAQ: VITL) August 2023 Corporate Presentation 2 REPORTING DISCLAIMER Non-GAAP Financial Measures This presentation contains, in addition to historical information, certain forward-looking statements, as defined in Private Securities Litigation Reform Act of 1995, that are based on our current assumptions, expectations and projections about future performance and events and relate to, among other matters, our future financial performance, our business strategy, industry and market trend ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 25, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number: 001-39411 Vital Farms, Inc. (Exact name of registrant as specified in its charter) Delaware 27-0496985 ...

Vital Farms, Inc. (NASDAQ:VITL) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Matt Siler - VP, IR Russell Diez-Canseco - President and CEO Thilo Wrede - CFO Kathryn McKeon - Chief Marketing Officer Conference Call Participants Adam Samuelson - Goldman Sachs Pamela Kaufman - Morgan Stanley Cody Ross - UBS Matt McGinley - Needham Robert Dickerson - Jefferies Matt Smith - Stifel Ben Klieve - Lake Street Capital Markets Matt Siler - VP, IR Operator Good day, and thank you for stand ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 26, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number: 001-39411 Vital Farms, Inc. (Exact name of registrant as specified in its charter) Delaware 27-049698 ...